All stock lists
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$10.64+$0.02 (+0.19%)
Market cap
$898M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 23, 2016
Website
Insider Score
82/ 100
CRVS Insider Score
Bullish4 qualifying trades · 1 insider · $50.48K bought in the last 90 days
CRVS analyst forecast
CRVS analyst consensus
No analyst ratings in the last 3 months.
CRVS 12-month price target
$33.00+210.2% upsideaverage of 3 firms
$42.00High
$27.00Low
Best analysts covering CRVS
- HC Wainwright & Co.100%success rate · +176.9% avg return · 2 calls
- Oppenheimer80%success rate · +155.8% avg return · 5 calls
- Jefferies0%success rate · -70.2% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CRVS analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-03-13 |
| Mizuho Securities | Outperform | $30.00 | +46.1% | Price target | 2026-01-29 | |
| Jefferies | Buy | $42.00 | +62.8% | Reiterated | 2026-01-22 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-21 |
| HC Wainwright & Co. | Buy | $27.00 | +48.2% | Reiterated | 2026-01-20 |
CRVS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-12 | -$0.14 | -$0.15 | $775K | $0 |
| 2026-05-07 | -$0.14 | -$0.15 | $0 | $0 |
| 2026-08-06 | -$0.16 | -$0.19 | $0 | $0 |
| 2026-11-05 | -$0.19 | -$0.22 | $0 | $0 |
| 2027-03-11Upcoming | -$0.24 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.